Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Dialogues in Clinical Neuroscience|April 28, 2006
A dopaminergic deficit hypothesis of schizophrenia: the path to discoveryArvid Carlsson, Maria L Carlsson
Brain Research Reviews|May 31, 2008
Adaptive properties and heterogeneity of dopamine D(2) receptors - pharmacological implicationsArvid Carlsson, Maria L Carlsson
Nature Reviews. Drug Discovery|February 14, 2009
The 'atypicality' of antipsychotics: a concept re-examined and re-definedGerhard Gründer, Hanns Hippius, Arvid Carlsson
Archives of General Psychiatry|October 15, 2003
Mechanism of new antipsychotic medications: occupancy is not just antagonismGerhard Grunder, Arvid Carlsson, Dean F Wong
Developmental Medicine and Child Neurology|July 3, 2004
Interhemispheric transfer in high-functioning children and adolescents with autism spectrum disorders: a controlled pilot studyAgneta Nydén, Maria Carlsson, Arvid Carlsson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
Nicotine treatment of obsessive-compulsive disorderStefan Lundberg, Arvid Carlsson, Per Norfeldt, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 26, 2005
The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in ratsJohan P Rung, Arvid Carlsson, Katarina Rydén Markinhuhta, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 27, 2005
(+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophreniaJohan P Rung, Arvid Carlsson, Katarina Rydén Markinhuhta, et al.
Biological Psychiatry|July 24, 2012
The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbensPia Steensland, Ida Fredriksson, Sarah Holst, et al.
Pageof 3